Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Platform: GPL21290 | |||||||
GSE246923 |
Opposing tumor cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in anti-tumor immunity
|
49 | Prabhat Kumar Purbey | May 01, 2024 | ||||
GSE244125 |
Endonucleolytic RNA cleavage drives changes in gene expression during the innate immune response
|
27 | Nicholas R Guydosh | Apr 30, 2024 | ||||
GSE244176 |
Endonucleolytic RNA cleavage drives changes in gene expression during the innate immune response [ribosome profiling]
|
14 | Nicholas R Guydosh | Apr 30, 2024 | ||||
GSE178211 |
ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models
|
18 | Narendra Wajapeyee | Apr 29, 2024 | ||||
GSE215917 |
Development and validation of AI/ML derived splice-switching oligonucleotides
|
22 | Alyssa Fronk | Apr 25, 2024 | ||||
GSE244205 |
TCAF1 Promotes TRPV2-mediated Ca2+ Release in Response to Cytosolic DNA to Protect Stressed Replication Forks
|
8 | Abigael Cheruiyot | Apr 24, 2024 | ||||
GSE264420 |
Activation of MEK‐ERK‐c‐MYC signaling pathway promotes splenic M2 macrophage polarization to inhibit PHcH-liver cirrhosis
|
12 | wang gui hu | Apr 24, 2024 | ||||
GSE241273 |
Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters [ChIP-Seq]
|
42 | Peggy J Farnham | Apr 23, 2024 | ||||
GSE241284 |
Reduction of ZFX levels decreases histone H4 acetylation and increases Pol2 pausing at target promoters
|
74 | Peggy J Farnham | Apr 23, 2024 | ||||
GSE211354 |
The SAGA complex maintains the oncogenic gene expression program in MYCN-amplified neuroblastoma [RNA-Seq]
|
54 | Gabriela Alexe | Apr 19, 2024 | ||||
GSE211355 |
The SAGA complex maintains the oncogenic gene expression program in MYCN-amplified neuroblastoma
|
92 | Gabriela Alexe | Apr 19, 2024 | ||||
GSE248036 |
XRN1 deletion induces PKR-dependent cell lethality in interferon-activated cancer cells
|
42 | Matthew Meyerson | Apr 17, 2024 | ||||
GSE263890 |
Combined bioinformatic and clinical assay uncovers resistance and susceptibility mechanisms of human glioblastomas to temozolomide and identifies new survival biomarkers outperforming MGMT promoter methylation
|
4 | Alexander Modestov | Apr 17, 2024 | ||||
GSE261067 |
Tumor mitochondrial oxidative phosphorylation stimulated by the nuclear receptor RORγ represents an effective therapeutic opportunity in osteosarcoma
|
7 | zheng jianwei | Apr 15, 2024 | ||||
GSE231525 |
DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer [BT474]
|
12 | Teemu Daniel Laajala | Apr 13, 2024 | ||||
GSE231526 |
DUSP6 inhibition overcomes Neuregulin/HER3-driven therapy resistance in HER2+ breast cancer
|
18 | Teemu Daniel Laajala | Apr 12, 2024 | ||||
GSE232360 |
MYCT1 Controls Environmental Sensing in human Hematopoietic Stem Cells [RNA-seq]
|
2 | Júlia Aguadé-Gorgorió | Apr 08, 2024 | ||||
GSE232362 |
MYCT1 Controls Environmental Sensing in human Hematopoietic Stem Cells.
|
9 | Júlia Aguadé-Gorgorió | Apr 08, 2024 | ||||
GSE237169 |
Regulation of mRNA translation by RNH1 in hematopoietic cells
|
6 | Mayuresh Sarangdhar | Mar 20, 2024 | ||||
GSE168897 |
Alternative polyadenylation is a minor feature of primary human muscle differentiation
|
24 | Akriti Varshney | Mar 12, 2024 |